ArticleTranslational lung cancer research2022

Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studies.

Kinnosuke Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.